Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India

  1. Rezwanuzzaman Laskar
  2. Safdar Ali

Reviewed by

Read the full article See related articles

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.gene.2021.145470
  2. ScreenIT

    SciScore for 10.1101/2020.10.19.345066: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board Statementnot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    Nucleotide Analysis: MEGA(v.10) is a multithreaded tool for molecular and evolutionary analysis.
    MEGA(v.10
    suggested: None
    We used these tools for annotation, identification and classification of mutated protein followed by verification and validation of the positions with the mutated nucleotide sites by the output of MEGA.
    MEGA
    suggested: (Mega BLAST, RRID:SCR_011920)
    The nucleotide similarity percentage was validated by NCBI BLAST (blast.ncbi.nlm.nih.gov) to investigate the sequence diversity.
    NCBI BLAST
    suggested: (NCBI BLAST, RRID:SCR_004870)
    It is expected that a SIFT score of < 0.05 is diseased (“affect protein function”), and that > 0.05 is neutral (“tolerated”).
    SIFT
    suggested: (SIFT, RRID:SCR_012813)
    This is stated that a PROVEAN score of < −2.5 is diseased (“deleterious”), and > −2.5 is neutral.
    PROVEAN
    suggested: (PROVEAN, RRID:SCR_002182)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • No funding statement was detected.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  3. Version published to 10.1101/2020.10.19.345066v1 on bioRxiv